NASDAQ · Medical - Diagnostics & Research

PRPO (PRPO) Stock

$21.19 -3.02% NASDAQ: PRPO Healthcare

Valuation

MetricValue
Price$21.19
Market Cap$37.87M
P/E Ratio-96.74
P/B Ratio2.80
P/S Ratio1.52
EPS (TTM)$-0.23
52-Week High$33.63
52-Week Low$10.52
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-7.13%
ROA-5.74%
ROCE-7.14%
Gross Margin43.27%
Operating Margin-6.79%
Net Margin-3.53%
Debt/Equity0.25
Current Ratio1.50

Annual Financials (USD)

Metric20212022202320242025
Revenue$9.0M$9.0M$15.0M$16.0M$24.0M
Operating Profit$-10.0M$-13.0M$-8.0M$-4.0M$-1.0M
Net Profit$-9.0M$-12.0M$-6.0M$-4.0M$0
EPS$-8.10$-10.73$-4.51$-2.93$-0.23
Op Margin-108.6%-136.0%-50.1%-26.4%-5.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$30.0M$22.0M$18.0M$17.0M$21.0M
Total Liabilities$6.0M$5.0M$4.0M$5.0M$7.0M
Cash$12.0M$3.0M$2.0M$1.0M$6.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$4.0M

Latest News

PRPO vs. NEO: Which Cancer Diagnostics Stock Is the Better Buy? Zacks · Jul 16, 2026 The Zacks Analyst Blog Highlights Caterpillar, Palo Alto Networks, Toyota Motor and Precipio Zacks · Jun 29, 2026 Top Analyst Reports for Caterpillar, Palo Alto & Toyota Zacks · Jun 26, 2026 Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting GlobeNewswire · Jun 12, 2026 Precipio to Present at the Planet MicroCap Las Vegas GlobeNewswire · Jun 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-8.0M$-4.0M$0$1.0M
Investing Cash Flow$-1.0M$-1.0M$0$0$-1.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$9.0M$-8.0M$-2.0M$0$1.0M
Free Cash Flow$-7.0M$-8.0M$-4.0M$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA-113.45
FCF Yield1.40%
Quick Ratio1.33
Interest Coverage—
Return 1Y58.12%
Return 3Y241.67%
Return 5Y-61.18%

Ownership

Insiders Held12.65%
Institutions Held17.66%
Institutions Float Held20.21%
Institutional HolderSharesReport Date
Blackrock Inc.29,0222026-03-31
Vanguard Capital Management LLC25,4832026-03-31
Topline Capital Management, LLC24,6242026-03-31
Renaissance Technologies, LLC19,3002026-03-31
Geode Capital Management, LLC18,8112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APUS $5.15 +4.67% -7.51 $7.77M 0.00%
INTS $4.57 +2.70% -0.60 $12.35M 0.00%
ITRMIterum Therapeutics plc $0.03 -10.98% -0.06 $1.60M 0.00%
LDDDLongduoduo Company Limited $0.51 +0.00% -43.59 $15.31M 0.00%
MLSS $0.40 +3.13% -10.04 $35.59M 0.00%

About PRPO

PRPO is led by CEO Ilan Danieli, employs 54 people, headquartered in US, publicly traded since 2017.

PRPO stock trades at $21.19 with a market capitalization of $37.87M. The stock is valued at a price-to-earnings (P/E) ratio of -96.74, price-to-book of 2.80, price-to-sales of 1.52. Over the past 52 weeks the stock has ranged between $10.52 and $33.63, and currently trades 37.0% below its 52-week high.

On profitability, PRPO generates a return on equity (ROE) of -7.13%, return on capital employed of -7.14%, an operating margin of -6.79%, a net profit margin of -3.53%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides